Skip to main content

Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480.

Publication ,  Conference
Taplin, ME; George, DJ; Halabi, S; Sellers, WR; Sanford, B; Hennessy, KT; Mihos, GG; Small, EJ; Kantoff, PW
Published in: JOURNAL OF CLINICAL ONCOLOGY
July 15, 2004

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

396S / 396S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Taplin, M. E., George, D. J., Halabi, S., Sellers, W. R., Sanford, B., Hennessy, K. T., … Kantoff, P. W. (2004). Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 396S-396S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY.
Taplin, M. E., D. J. George, S. Halabi, W. R. Sellers, B. Sanford, K. T. Hennessy, G. G. Mihos, E. J. Small, and P. W. Kantoff. “Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480.” In JOURNAL OF CLINICAL ONCOLOGY, 22:396S-396S. AMER SOC CLINICAL ONCOLOGY, 2004.
Taplin ME, George DJ, Halabi S, Sellers WR, Sanford B, Hennessy KT, et al. Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 396S-396S.
Taplin, M. E., et al. “Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480.JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, AMER SOC CLINICAL ONCOLOGY, 2004, pp. 396S-396S.
Taplin ME, George DJ, Halabi S, Sellers WR, Sanford B, Hennessy KT, Mihos GG, Small EJ, Kantoff PW. Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 396S-396S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

396S / 396S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences